Hematology

Top Story

Fewer blood transfusions used for major oncologic abdominal surgery

Fewer blood transfusions used for major oncologic abdominal surgery
April 29, 2016

Fewer perioperative blood transfusions have occurred for oncologic abdominal surgery over the last 9 years, according to results of a retrospective review of a population-based registry.

“The relative risks and benefits of allogeneic blood transfusion are particularly complex for the oncological surgery patient,” Giorgos C. Karakousis, MD, FACS, assistant professor of surgery at the Hospital at the University of Pennsylvania and chair of the cancer committee at the Abramson Cancer Center in the Perelman School of Medicine, and colleagues wrote. “Transfusion-related immunomodulation has been recognized for more than 30 years, when it was observed that renal allograft survival was improved with preoperative blood transfusion. Whether the immunosuppressive effects of allogeneic transfusion are associated with an increased risk of cancer recurrence has not been definitely established, although associations in a variety of abdominal malignant tumors have been observed.”

In the Journals

Treatment reduces malaria incidence via blood transfusion in Ghana

April 27, 2016
Treating donated whole blood with a combination of ultraviolet radiation and vitamin B2 significantly reduced the incidence of transfusion-transmitted malaria at a…
In the Journals

Comprehensive screening fails to increase occult cancer detection after unprovoked VTE

April 25, 2016
The addition of 18F-fluorodeoxyglucose PET/CT scans to limited screening did not appear to significantly increase the rate of occult cancer detection in patients who…
In the Journals

Resistant E. coli, E. faecium CLABSIs prevalent among oncology settings

April 22, 2016
Data reported to the CDC indicated that central line-associated bloodstream infections, or CLABSIs, resulting from fluoroquinolone-resistant Escherichia coli and…
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Video
At Issue

VIDEO: Stem cell transplant for myeloma ‘here to stay,’ stands to improve with help of new agents

March 4, 2016
More »
Featured
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center

CME

The Patient with Multiple Ecchymoses

No commercial support for this activity.

Glanzmann’s thrombasthenia is a rare, inherited bleeding disorder that results from a mutation in αIIbß3, an integrin…
More »
In the Journals

Fewer blood transfusions used for major oncologic abdominal surgery

April 29, 2016
Fewer perioperative blood transfusions have occurred for oncologic abdominal surgery over the last 9 years, according to results of a retrospective…
In the Journals

Treatment reduces malaria incidence via blood transfusion in Ghana

April 27, 2016
Treating donated whole blood with a combination of ultraviolet radiation and vitamin B2 significantly reduced the incidence of…
In the Journals

Comprehensive screening fails to increase occult cancer detection after unprovoked VTE

April 25, 2016
The addition of 18F-fluorodeoxyglucose PET/CT scans to limited screening did not appear to significantly increase the rate of occult cancer…
In the Journals

Resistant E. coli, E. faecium CLABSIs prevalent among oncology settings

April 22, 2016
Data reported to the CDC indicated that central line-associated bloodstream infections, or CLABSIs, resulting from fluoroquinolone-resistant…

Phase 3 study demonstrates ferric citrate effectively treats iron deficiency anemia

April 15, 2016
Keryx Biopharmaceuticals recently reported positive results of a pivotal phase 3 study that showed ferric citrate effectively increased the…
Meeting News Coverage

Top Takeaways from ASH: Hydroxyurea demonstrates noninferiority vs. transfusion for stroke prevention

April 14, 2016
Treatment with hydroxyurea for stroke prevention among children with sickle cell anemia appears to be a viable alternative to chronic transfusion…
FDA News

FDA grants priority review to Opdivo for classical Hodgkin lymphoma

April 14, 2016
The FDA granted priority review to expand the use of nivolumab for the treatment of classical Hodgkin lymphoma after prior therapies.The application…
Meeting News Coverage

Top Takeaways from ASH: Improved quality measures, new collaboration key to success in value-based models

April 5, 2016
A special symposium on quality at the ASH Annual Meeting and Exposition offered hematologists new insight on meaningful measures and accountability…
In the Journals

Despite advancements, men with severe hemophilia still experience frequent bleeding, disability

March 30, 2016
Although significant advancements in hemophilia treatment and access to integrated treatment centers have occurred in the last 50 years, men with…
FDA News

FDA approves Defitelio to treat hepatic VOD, multiorgan dysfunction after HSCT

March 30, 2016
The FDA today approved defibrotide sodium to treat adults and children who developed hepatic veno-occlusive disease with renal and pulmonary…
More Headlines »
morganatic-roan